BAIAP2L1 and obesity disorder: BAIAP2L1 is also known as IRTKS (insulin receptor tyrosine kinase substrate) which is involved in insulin receptor signaling [47] and may relate to insulin resistant states including obesity and T2D [48], [49], [50], [51], [52], [53], [54].